Skip to main content

Table 5 The subgroup analysis for the primary pregnant outcomes according to study design

From: Pretreatment with or without GnRH-agonist before frozen–thawed embryo transfer in patients with PCOS: a systematic review and meta-analysis

   

Fixed/Random model

Sensitivity analysis

Outcome

Numbers of participants

Subgroup

analysis

RR(95%CI)

I2 (%)

Heterogeneity (P)

RR(95% CI)

I2 (%)

Heterogeneity (P)

Implantation

2807

RCT

0.89(0.63, 1.24)

55.8

0.132

0.89(0.63,1.24)

55.8

0.132

  

Case-controlled

1.16(1.03, 1.32)

65.0

0.004

1.21(1.05,1.39)

63.6

0.007

  

Total

1.12(1.00, 1.24)

63.7

0.002

1.14(1.01,1.29)

64.5

0.003

Clinical pregnancy

3640

RCT

1.04(0.81,1.34)

51.4

0.103

1.04(0.81,1.34)

51.4

0.103

  

Case-controlled

1.24(1.11,1.38)

60.4

0.002

1.28(1.13,1.44)

57.9

0.006

  

Total

1.19(1.08, 1.32)

59.0

0.001

1.22(1.10,1.36)

58.5

0.002

Miscarriage

2091

RCT

0.83(0.53,1.29)

59.3

0.061

0.79(0.32,1.95)

57.4

0.071

  

Case-controlled

0.81(0.63,1.06)

0.0

0.709

0.87(0.66,1.15)

0.0

0.896

  

Total

0.82(0.65, 1.02)

2.2

0.428

0.89(0.70,1.31)

0.0

0.619

  1. RR Pooled relative risk, RCT Randomized controlled trial